(196 days)
Not Found
Not Found
No
The summary describes a change in the material of a dental implant and does not mention any software, algorithms, or data processing that would indicate the use of AI/ML.
No
The device is an implant system designed for dental implant surgery, replacing missing natural teeth with artificial ones. While it helps restore function, it is not primarily for treating a disease or disorder but rather for structural replacement and restoration.
No
The device described is a dental implant system, designed for surgical implantation into the jawbone. Its purpose is to replace missing teeth and integrate osseously with the bone, rather than to diagnose medical conditions or diseases.
No
The device description explicitly states it includes bone-implantable titanium and titanium alloy implants, which are hardware components. The submission describes a change in the material of these physical implants, not a software component.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is for "dental implant surgery" and involves surgically inserting implants into the jawbones. This is a surgical procedure performed directly on the patient's body.
- Device Description: The device is a physical implant made of titanium or titanium alloy, designed to be surgically placed.
- Lack of In Vitro Activity: There is no mention of the device being used to examine specimens derived from the human body (like blood, urine, tissue samples, etc.) outside of the body to provide information for diagnosis, monitoring, or treatment.
IVD devices are used to perform tests on samples taken from the body to provide diagnostic information. This device is a surgical implant used for structural support and restoration within the body.
N/A
Intended Use / Indications for Use
"The 3i Implant System is designed for use in dental implant surgery. The 3i Implant System includes a variety of types and sizes of specially designed bone-implantable titanium and titanium alloy implants. These implants are surgically inserted into the upper and/or lower jawbones.
A successfully osseointegrated implant will achieve a firm and direct connection between the living bone and the surface of the titanium or titanium alloy implant when surgically implanted under controlled conditions, per well known clinical studies.
Product codes (comma separated list FDA assigned to the subject device)
Not Found
Device Description
3i's Endosseous screw type dental implants have historically been constructed of Commercially Pure (CP) Titanium, and are available in diameters between 3.25 and 6.00mm and lengths between 7.00 and 20.0mm.
This change covers all styles, sizes, and lengths of 3i's screw type implants and pertains to a new alloy, that will be used in the production of the implants; from previously recognized Commercially Pure (CP) Titanium, to a Titanium Alloy identified as Ti-13Nb-13Zr.
There is no change in the manufacturing or processing operations from those employed using the original material. The implants are machined, finished, cleaned packaged and sterilized. A placement instrument and cover screw (where specified), will be included with the implant.
Sterilization shall be accomplished using Co60 Irradiation, at a dose providing for a Sterility Assurance Level (SAL) of ten to the minus six.
Validation of sterilization shall be accomplished as specified by AAMI (Association for the Advancement of Medical Instrumentation) Guidelines.
Irradiation sterilization shall be accomplished by an FDA registered Irradiation sterilization facility.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
upper and/or lower jawbones.
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Extensive physical and biological testing of the Alloy Ti-13Nb-13Zr has been performed by the developer and is currently used in orthopedic implant applications.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Not Found
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 872.3640 Endosseous dental implant.
(a)
Identification. An endosseous dental implant is a prescription device made of a material such as titanium or titanium alloy that is intended to be surgically placed in the bone of the upper or lower jaw arches to provide support for prosthetic devices, such as artificial teeth, in order to restore a patient's chewing function.(b)
Classification. (1) Class II (special controls). The device is classified as class II if it is a root-form endosseous dental implant. The root-form endosseous dental implant is characterized by four geometrically distinct types: Basket, screw, solid cylinder, and hollow cylinder. The guidance document entitled “Class II Special Controls Guidance Document: Root-Form Endosseous Dental Implants and Endosseous Dental Implant Abutments” will serve as the special control. (See § 872.1(e) for the availability of this guidance document.)(2)
Classification. Class II (special controls). The device is classified as class II if it is a blade-form endosseous dental implant. The special controls for this device are:(i) The design characteristics of the device must ensure that the geometry and material composition are consistent with the intended use;
(ii) Mechanical performance (fatigue) testing under simulated physiological conditions to demonstrate maximum load (endurance limit) when the device is subjected to compressive and shear loads;
(iii) Corrosion testing under simulated physiological conditions to demonstrate corrosion potential of each metal or alloy, couple potential for an assembled dissimilar metal implant system, and corrosion rate for an assembled dissimilar metal implant system;
(iv) The device must be demonstrated to be biocompatible;
(v) Sterility testing must demonstrate the sterility of the device;
(vi) Performance testing to evaluate the compatibility of the device in a magnetic resonance (MR) environment;
(vii) Labeling must include a clear description of the technological features, how the device should be used in patients, detailed surgical protocol and restoration procedures, relevant precautions and warnings based on the clinical use of the device, and qualifications and training requirements for device users including technicians and clinicians;
(viii) Patient labeling must contain a description of how the device works, how the device is placed, how the patient needs to care for the implant, possible adverse events and how to report any complications; and
(ix) Documented clinical experience must demonstrate safe and effective use and capture any adverse events observed during clinical use.
0
Image /page/0/Picture/0 description: The image shows a logo with a stylized letter 'i' as its main element. A triangular shape is positioned to the left of the 'i', partially obscuring it. The word 'INNOVATIONS' is written in bold, sans-serif font below a horizontal line at the bottom of the image.
West Palm Beach, FL 33407 1-800-443-8166 (407) 840-2600 FAX (407) 840-2660
APR - 1 1996
Exhibit 8
SUMMARY OF SAFETY AND EFFECTIVENESS INFORMATION TO SUPPORT A DETERMINATION OF SUBSTANTIAL EQUIVALENCE OF IMPLANT INNOVATIONS' Ti1313 THREADED IMPLANTS
510(k) SUBMISSION: MATERIAL CHANGE - TITANIUM ALLOY (Ti1313), FOR SCREW FORM ENDOSSEOUS DENTAL IMPLANTS.
-
- CLASSIFICATION NAME: Endosseous Dental Implants
-
- COMMON/USUAL NAMES: Standard Threaded Implants, Self-Tapping Threaded Implants, Miniplants (TM).
-
- PROPRIETARY NAME: 3i Standard Threaded Implant. 3i Self-Tapping Threaded Implants and 3i Miniplant (TM) Implants. All included in the original Pre-Market Notification, titled "Innovative Implants and Cover Screws".
-
- CLASSIFICATION: Endosseous dental implants, per 872.3640 have been classified as class III devices. PMA's may be required for some or all designs of endosseous dental implants in the future, but no effective date has been established for PMA submission.
-
- PERFORMANCE STANDARDS: Not applicable at this time.
-
- FORM: 3i's Endosseous screw type dental implants have historically been constructed of Commercially Pure (CP) Titanium, and are available in diameters between 3.25 and 6.00mm and lengths between 7.00 and 20.0mm.
This change covers all styles, sizes, and lengths of 3i's screw type implants and pertains to a new alloy, that will be used in the production of the implants; from previously recognized Commercially Pure (CP) Titanium, to a Titanium Alloy identified as Ti-13Nb-13Zr.
Extensive physical and biological testing of the Alloy Ti-13Nb-13Zr has been performed by the developer and is currently used in orthopedic implant applications.
There is no change in the manufacturing or processing operations from those employed using the original material. The implants are machined, finished, cleaned packaged and sterilized. A placement instrument and cover
1
screw (where specified), will be included with the implant.
Sterilization shall be accomplished using Co60 Irradiation, at a dose providing for a Sterility Assurance Level (SAL) of ten to the minus six.
Validation of sterilization shall be accomplished as specified by AAMI (Association for the Advancement of Medical Instrumentation) Guidelines.
Irradiation sterilization shall be accomplished by an FDA registered Irradiation sterilization facility.
-
- LABEL/LABELING MATERIALS: The proposed process changes will not necessitate a revision to the device labeling or instruction sheets, other than catalog number and description, stating Ti-13Nb-13Zr instead of Commercially Pure Titanium. There are no promotional materials in development at this time.
-
- SUBSTANTIAL EQUIVALENCE:
This material change will not alter the previously obtained substantial equivalence determination for the 3i threaded implants. This is based upon the fact that there has been no change in the implant design, other than the proposed change to Ti-13Nb-13Zr, and there are no other changes in manufacturing or processing. 3i İs making no claims relative to these changes at this time, and indications for use of the 3i threaded implant system have not changed and do not substantially differ from those offered by other dental device manufacturers.
-
- INDICATION FOR USE:
"The 3i Implant System is designed for use in dental implant surgery. The 3i Implant System includes a variety of types and sizes of specially designed bone-implantable titanium and titanium alloy implants. These implants are surgically inserted into the upper and/or lower jawbones.
- INDICATION FOR USE:
A successfully osseointegrated implant will achieve a firm and direct connection between the living bone and the surface of the titanium or titanium alloy implant when surgically implanted under controlled conditions, per well known clinical studies.
10. CONTRAINDICATIONS:
3i implants should not be used in cases where the remaining jaw bone is too diminished to provide adequate width or height to surround the implant. Lack of osseointegration or subsequent implant failure may occur
2
in cases where there is insufficient available bone , poor bone quality, poor oral hygiene, heavy smoking or tobacco abuse, or medical conditions such as blood disorders or uncontrolled diabetes.
-
- WARNINGS:
For safe and effective use of 3i implants, it is strongly suggested that specialized training be undertaken since the surgical techniques required to place dental implants are highly specialized and complex procedures. Improper patient selection and technique can cause implant failure and/or loss of supporting bone.
- WARNINGS:
-
- PRECAUTIONS:
Thorough screening of prospective implant candidates must be performed. Visual inspection as well as panoramic and pariapical radiographs are essential to determine anatomical landmarks, occlusal conditions, pariodontal status, and adequacy of bone. Lateral cephalometric radiographs, CT Scans, and tomograms may also be beneficial.
- PRECAUTIONS:
-
- ADVERSE EFFECTS:
Loss of implant anchorage (failure to osseointegrate) and loss of the prosthesis are possible occurrences after surgery. Lack of quantity or quality of remaining bone, infections, poor patient oral hygiene or cooperation, and generalized diseases (diabetes, etc.) are some potential causes for loss of anchorage.
- ADVERSE EFFECTS:
-
- SURGICAL COMPLICATIONS:
The implant procedure has risks, including localized swelling, dehiscence, tenderness of short duration, edema, hematoma, or bleeding.
- SURGICAL COMPLICATIONS:
Numbness of the lower lip and chin region following lower jaw surgery, and of the tissue beside the nose following upper jaw surgery, is a possible side effect of the surgery. Though it would most probably be of a temporary nature, in very rare cases, the numbness has been permanent.
Gingival/Mucosal (gum tissue) ulceration, tissue reaction, or infection may occur, but generally responds to local care.
-
- PRE-MARKET NOTIFICATION CERTIFICATION AND SUMMARY FOR SUBMISSION:
I certify that I have conducted a reasonable search of
- PRE-MARKET NOTIFICATION CERTIFICATION AND SUMMARY FOR SUBMISSION:
3
all information known or otherwise available to me about the types and causes of safety and/or effectiveness problems that have been reported for Endosseous Dental Implant systems.
Failure to osseointegrate or loss of osseointegration can be caused by improper patient selection (patients with systemic diseases which affect bone physiology, patients with habits such as bruxing or clenching, patients who are physically or psychologically unable to carry out proper implant hygiene, heavy smoking or alcohol use), by improper surgical technique (overheating of bone) or improper case planning or restorative technique (overloading of implants through improper placement, use of an insufficient number of implants or excessive cantilever). Improper implant processing by the manufacturer or improper handling by the customer, resulting in contamination, can also effect osseointegration.
Fracture of implants can occur, particularly in implants with apical cross-holes. Fracture occurs either on insertion of screw-type implants due to excessive torque (improper surgical technique such as an error in drill selection) or in service due to loss of bone.
Fracture of abutments and abutment screws occurs in implant systems and is usually attributed to factors within the control of the implant team, such as lack of passive fit of the restoration or excessive cantilever, or within the control of the patient, such as bruxing.
Other types of safety and efficacy problems which have been observed for endosseous dental implant systems are local soft tissue degeneration and bone resorption, paresthesia, perforation of the maxillary sinus, perforation of labial and lingual plates, local and systemic infection, prosthetic framework fracture, nerve injury, bone fracture, injury to adjacent teeth and their supporting bone, oroantral or oronasal fistula, gingival hyperplasia, soft tissue overgrowth, perforation of the gingiva by the healing screw, mucosal abscess, displacement of the implant into the mandibular canal, hemorrhage of the floor of the mouth due to transection of the sublingual artery and breakage of drill tip, requiring surgical removal.
Will
William G/ Conety Director, Requlatory Affairs/Quality Assurance